Clinical data | |
---|---|
Trade names | Glanatec |
Other names | K-115 |
Routes of administration | Topical (ophthalmic solution) |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H18FN3O2S |
Molar mass | 323.39 g·mol−1 |
3D model (JSmol) | |
| |
|
Ripasudil (trade name Glanatec), a derivative of fasudil, is a rho kinase inhibitor drug (previously known as K-115)[1] used for the treatment of glaucoma and ocular hypertension.